This is where study results will be published when they become available.
The studies are listed alphabetically for ease.
AvonCAP Study Results
The AvonCAP study undertook an analysis using a case-control approach to evaluate the effectiveness of COVID-19 vaccines. The results provided further evidence that one dose of both Pfizer and Oxford-AstraZeneca COVID-19 vaccination are effective both in an older age-group less studied in the trials and for an outcome which was rarer in the trials than in ‘real-world’ use, namely hospitalisations.
Please take a look at the AvonCAP Infectious Disease Lancet Paper (PDF, 630kB) for the full story!